cdmo.directory
← Compare landing

BioInnovatise vs Cell and Gene Therapy Catapult

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioinnovatise/ct

CategoryBioInnovatiseCell and Gene Therapy Catapult
Listed sitecdmocdmo
SummaryBioInnovatise provides fast, reliable CDMO services for plasmid DNA, viral vector packaging, and CRISPR-Cas9 research with turnaround times of 7–28 days.UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.
Services
  • Cell-Line Development
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Translational Research
  • Discovery Research
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Upstream Processing
  • Downstream Processing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
Modalities
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
  • Rare Disease
LocationsData not yet provided.
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.